NPPA slaps Rs 4.92 crore demand notice on Natco Pharma for overcharging 
Corporate Watch

NPPA slaps Rs 4.92 crore demand notice on Natco Pharma for overcharging

Natco Pharma Ltd on Thursday said it has received a demand notice of over Rs 4.92 crore from NPPA for alleged overcharging for two drugs

PTI

New Delhi: Natco Pharma Ltd on Thursday said it has received a demand notice of over Rs 4.92 crore from the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging for two drugs.

Follow The PSUWatch Channel on WhatsApp

The National Pharmaceutical Pricing Authority (NPPA) has issued demand notice "under para 15 of Drugs Price Control Order, 2013 directing the company to deposit an amount of Rs 4,92,25,923, including overcharge amount, penalty and interest", Natco Pharma said in a regulatory filing.

Follow PSU Watch on LinkedIN

Also read:CSR non-compliance: Govt imposes Rs 20 crore penalties on companies in last 3 financial years

The demand notice alleges overcharging for two drugs covering the period between April 2023 and November 2023, it added.

There is no material impact on financial, operational and other activities of the company, it added.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)

Also Read

SEBI rationalises KYC norms for FPIs, extends review period to up to 8 years

Bank of Baroda Q2 profit up 31% to Rs 6,737 cr on NSE stake-sale

RBI central board reviews prevailing economic conditions

Adani Energy Solutions gets CCI nod to acquire IntelliSmart Infrastructure

TRAI proposes board-approved AI policies, mandatory reporting of serious incidents by telcos